News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Friday, October 24, 2014

Top Breaking News
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited
Amgen (AMGN) Lays Off 274 Employees As Part Of Its Exit From Washington State
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid
Shire Stands To Grab $1.6B From AbbVie (ABBV) In Third Largest Breakup Fee In History
New Actavis (ACT) CEO Has $70 Billion In Deals To Choose From
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst
Five Prime Therapeutics, Inc. (FPRX) Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline (GSK)
Billionaire Paul G. Allen Pledges $100 Million To Fight Ebola
Baxter International, Inc. (BAX)'s Hemophilia A Drug Obizur Wins FDA Approval
FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc. (NPSP)'s Natpara
New AbbVie (ABBV) Head Blasts Canada’s Patent Laws On Drugs
Hikma Pharmaceuticals (HIK.L) Falls On FDA Warning For Portugal Plant
KeraNetics, LLC Quadrupling Manufacturing Space With Plan To Move Into Targacept, Inc. (TRGT)'s Old Haunts
AstraZeneca PLC (AZN)'s Cancer Drug Pipeline Gets Boost From European Green Light
Genmab A/S (GEN.CO) Banks $10 Million Milestone Payment From Janssen Biotech Inc. (JNJ)
QLT Inc. (QLTI) Appoints Dr. Geoffrey F. Cox As Interim CEO

Featured Stories

More News
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business
Europe Approves Clinuvel's Novel Australian Drug Developed For Rare Sun Disease
Ariad Pharmaceuticals, Inc. (ARIA) Announces Adoption of Final Opinion For Iclusig By Committee For Medicinal Products For Human Use In Europe
Mundipharma AG Receives Positive CHMP Opinion For Targin® (Oxycodone / Naloxone) For The Treatment Of Restless Legs Syndrome1
Astellas Pharma Inc. (ALPMY)'s XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve
Roche (RHHBY) Release: CHMP Recommends Label Update For Esbriet In Idiopathic Pulmonary Fibrosis, Strengthening Mortality Benefit And Reinforcing Safety Profile
Rhythm Presents Positive Phase 2 Study Results For Relamorelin For Chronic Constipation
Verastem, Inc. (VSTM) Presents New Data On Mesothelioma Programs At The 12th International Mesothelioma Interest Group Meeting
Clovis Oncology (CLVS) Announces First Patient Enrolled In Lucitanib Phase 2 Study In Squamous Non-small Cell Lung Cancer
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS – FDA Response To Phase 2b Study Plans
Aduro Biotech Presents Updated Interim Results From Phase 1b Clinical Trial In Mesothelioma At International Mesothelioma Interest Group Conference
Vitae Pharmaceuticals, Inc. (VTAE) Release: Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials Of BACE Inhibitor BI1181181/VTP-37948 In Alzheimer's Disease
Kaiser Permanente Release: Mother's Gestational Diabetes Linked To Daughters Being Overweight Later
Kaiser Permanente Study Finds Significant Increase In Rates Of Type 1 Diabetes Among U.S. Non-Hispanic White Youth
Imprimis Pharmaceuticals (immy) Reports On Positive Clinical Findings Presented At The American Academy of Ophthalmology Annual Meeting
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model
Glythera Unveils ADC Cysteine Linker Technology
Case Western Reserve University Release: New Compounds Reduce Debilitating Inflammation
Stellar Biotechnologies, Inc. And Biovest International, Inc. Sign KLH Supply Agreement For BiovaxID Immunotherapy For Follicular Non-Hodgkin's Lymphoma
Medivation, Inc. (MDVN) Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. For Potential Applications In Oncology
National Stem Cell Foundation Release: Stem Cell And Orthopaedic Foundations Partner On Stem Cell Research
European Medicines Agency Completes Review Of Polymyxin-Based Medicines
PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change And Launches New Corporate Website
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $6 Million
Global Bioenergies: One Step Closer To Industrial Pilot Testing
ERYtech Pharma: Prospectus Made Available After Obtaining Visa N° 14-566 From The French Financial Markets Authority
AptarGroup Declares Quarterly Dividend
Zafgen (ZFGN) To Ring The Nasdaq Stock Market Closing Bell
Americord Launches Revolutionary Stem Cell Collection Process
Amgen (AMGN) To Webcast 2014 Business Review Meeting On October 28
CDC Supports Recruitment For MediciNova, Inc.'s Clinical Trial Of MN-166 (Ibudilast) In ALS
Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P
ALS ACT, The ALS Association, And The Northeast ALS Consortium Issue Request For Proposals For Phase 2 Clinical Development Of Novel, High-Potential Treatments For ALS
Biomax Informatics launches BioXM™ Knowledge Management Environment Version 5.1
ALIGN Pharmaceuticals, Inc. Announces Third Quarter 2014 Results
Alimera Sciences (ALIM) To Release Third Quarter 2014 Results
Amgen (AMGN) Announces Webcast of 2014 Third Quarter Financial Results
Albany Molecular Research, Inc. (AMRI) (AMRI) To Announce Third Quarter Results On November 5, 2014
Alder Biopharmaceuticals Inc. To Host Conference Call To Discuss Third Quarter 2014 Financial And Operating Results
Aceto Corporation Schedules First Quarter Fiscal 2015 Financial Results News Release And Conference Call
BioMarin Pharmaceutical Inc. (BMRN) Announces Third Quarter 2014 Financial Results
Bristol-Myers Squibb Company (BMY) Reports Third Quarter 2014 Financial Results
Edwards Lifesciences Corporation (EW) Reports Third Quarter Results
IGI Laboratories, Inc. Announces Third Quarter 2014 Results
IRIDEX Corporation (IRIX) Announces Third Quarter 2014 Conference Call And Release Date
ImmunoGen, Inc. (IMGN) Reports First Quarter Fiscal Year 2015 Financial Results
IMS Health Reports Third-Quarter 2014 Results
Oxford Immunotec Limited (OXFD) Schedules Third Quarter 2014 Earnings Release and Conference Call For November 4, 2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend
Pfizer (PFE) Declares 26-Cent Fourth-Quarter 2014 Dividend
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Third Quarter 2014 Financial Results
Pain Therapeutics (PTIE) To Host Conference Call To Discuss Q3 2014 Financial Results
Pacific Biosciences (PACB) Reports Third Quarter 2014 Financial Results
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Third Quarter 2014 Earnings Call
Shire’s Clear And Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings Per ADS Up 60%.
Sensient Technologies Corporation Reports Results For The Quarter Ended September 30, 2014
Tekmira (TKMR) Conference Call And Webcast Advisory: Corporate Update And Third Quarter Financial Results
TherapeuticsMD, Inc.  (TXMD) To Host Third Quarter 2014 Financial Results Conference Call And Webcast November 6
West Pharmaceutical Services To Host Third Quarter 2014 Conference Call
Sucampo Pharmaceuticals, Inc. (SCMP) Solidifies Leadership Team With Additions Of CSO And Heads Of Business Development, Regulatory Affairs
Elite Pharmaceuticals, Inc. (ELI) Announces New Management Appointments
BIOCOM Announces 2014 Elected Official Of The Year
AHF To Gilead Sciences, Inc. (GILD): Do Your Patriotic Duty And Lower Hep. C Drug Prices For Veterans
CHEST Foundation Launches Campaign To Encourage People With COPD To Live Well
Eisai Inc. (ESALF.PK) Launches "Search For The Next Medikidz Star" Contest For Kids Living With Epilepsy
MediciGlobal Supports TauRx Therapeutics Sponsorship Of "Meet The Experts" Event At International Conference On Frontotemporal Dementias
WuXi PharmaTech Co., Ltd. Congratulates TaiMed Biologics On Receiving Orphan Drug Designation For Ibalizumab From U.S. FDA
Axxess Pharma, Inc. To Showcase Full TapouT Product Line And Celebrity Sponsors To 50,000 US Military Personnel At Fort Hood, Texas In Early November
PPD, Inc. (PPDI) Renews Commitment To PPD Beach2Battleship Triathlon
Radius (RDUS) Sponsors The Cancer Support Community "Elevating The Patient Voice" Symposium In Recognition Of National Breast Cancer Awareness Month
Washington Biotechnology & Biomedical Association Release: Governor Jay Inslee Joins Washington’s Life Science Industry To Celebrate 25 Years Of Life-Changing Innovation
Elekta's Mosaiq Oncology Information System Ranks Number One In KLAS Oncology 2014 Report
GE Healthcare Life Sciences Wins Prestigious Bioprocessing Industry Award
Monsanto Company (MON) Named One Of The World's Best Multinational Workplaces
Alexion Pharmaceuticals Inc. (ALXN) Release: Researchers To Present Data On Soliris® (Eculizumab) As A Treatment For Patients With Ahus At American Society of Nephrology 2014 Annual Meeting
Clinovo Holds A Second Virtual Update To Showcase Brand New Features To Its Open Source EDC System, Clincapture, On October 30th
European Medicines Agency Release: Meeting Highlights From The Committee For Medicinal Products For Human Use (CHMP) 20-23 October 2014
Novavax, Inc. (NVAX) To Present RSV Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26
Synageva BioPharma (GEVA) Presents Sebelipase Alfa Data At The NASPGHAN Meeting
Pelvalon Announces New Analysis From The LIFE Pivotal Trial At The 2014 ICS Conference And Unveils The Brand Name For Its Vaginal Bowel Control Therapy
Edgar Staren, MD, PhD, And Stacie J. Stephenson, DC, To Address The Personalized Lifestyle Medicine Institute's Second Annual Thought Leaders Consortium
Head of Innovation For Bayer And The National Director For Patient And Information Of NHS England To Keynote Health 2.0 Europe 2014
Oramed Pharmaceuticals Inc. (ORMP) To Present At The FireRock Annual Micro-Cap Conference
La Jolla Pharmaceutical Company (LJPC) Announces Data Presentation At The American Society of Nephrology Kidney Week
The Association For Molecular Pathology Adds Late-Breaking Session On Laboratory Developed Procedures Oversight And Regulation To The 2014 Annual Meeting Program